Woodside Acquisitions Inc.

FDA Regulatory Profile

Woodside Acquisitions Inc. appears in FDA public data with 2 recalls — including 2 Class I (most serious) —, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (Z-1044-2022, Class I) was initiated on April 9, 2022.

Summary

Total Recalls
2 (2 Class I)
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
Z-1044-2022Class IOral Rapid SARS-CoV-2 Antigen Rapid Test Kit; COVID 19 TestApril 9, 2022
Z-1045-2022Class IJoysbio SARS-CoV-2 Antigen Rapid Test Kit (Colloidal Gold); COVID 19 TestApril 9, 2022